William Blair analyst Sami Corwin maintained a Buy rating on Applied Therapeutics (APLT – Research Report) today. The company’s ...

Equities research analysts at William Blair lowered their Q1 2025 earnings estimates for Wolfspeed in a report released on ...

Research analysts at William Blair boosted their Q2 2025 earnings per share (EPS) estimates for shares of Equifax in a ...

This estimate takes into account the company's growth trajectory and the potential for reinvestment and strategic acquisitions. According to William Blair, assuming a valuation of 33 times ...

Mehta and Taube complement the current appointments to William Blair’s investment banking team, which also includes Patrick ...

Fintel reports that on October 16, 2024, William Blair initiated coverage of Apellis Pharmaceuticals (NasdaqGS:APLS) with a ...

Starbucks (SBUX) has the money to tackle its staffing issues, according to William Blair analyst Sharon Zackfia. By investing ...

Fintel reports that on October 17, 2024, William Blair upgraded their outlook for Baldwin Insurance Group (NasdaqGS:BWIN) from Market Perform to Outperform. Analyst Price Forecast Suggests 12.59% ...

On Monday, Applied Therapeutics Inc (APLT) stock saw a modest uptick, ending the day at $8.99 which represents a slight increase of $0.03 or 0.33% from the prior close of $8.96. The stock opened at $8 ...

Quest Diagnostics reports strong Q3 with 8.5% sales growth, raises 2024 revenue guidance to $9.80 billion-$9.85 billion, ...

Mehta and Taube build on William Blair’s investment banking additions in recent months, including Derek Smith, managing director in tech-enabled services; Connor O'Keeffe, managing director in Private ...

In addition to the transaction, Kevin Twomey, a partner at WestView, will join the CardFlight board of directors.